DUPONT CAPITAL MANAGEMENT CORP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$223,457
+80.2%
18,889
-9.7%
0.01%
+57.1%
Q3 2022$124,000
-80.1%
20,914
-55.9%
0.01%
-53.3%
Q2 2018$624,000
-24.8%
47,454
-18.8%
0.02%
-25.0%
Q1 2018$830,000
+55.7%
58,421
-10.1%
0.02%
+66.7%
Q4 2017$533,000
+75.3%
64,957
+153.1%
0.01%
+71.4%
Q3 2017$304,000
+17.8%
25,6620.0%0.01%
+16.7%
Q2 2017$258,00025,6620.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders